PREDICTING PROSTATE CANCER SPECIFIC OUTCOME AFTER RADICAL PROSTATECTOMY AMONG MEN WITH PSA &[GE] 20 NG/ML WITH OR WITHOUT ADDITIONAL HIGH RISK FACTORS: A MULTI-INSTITUTIONAL OUTCOME STUDY OF 712 PATIENTS

被引:0
|
作者
Spahn, Martin
Gontero, Paolo
Kneitz, Burkhard
Tombal, Bertrand
Hsu, Belgium C-J
Van der Eeckt, Kathie
Marchioro, Giansilvio
Bader, Pia
Frohneberg, Detlef
Van Poppel, Hein
Joniau, Steven
机构
来源
JOURNAL OF UROLOGY | 2010年 / 183卷 / 04期
关键词
D O I
10.1016/j.juro.2010.02.837
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
578
引用
收藏
页码:E227 / E227
页数:1
相关论文
共 50 条
  • [41] Dose-escalated salvage radiotherapy after radical prostatectomy in high risk prostate cancer patients without hormone therapy: outcome, prognostic factors and late toxicity
    Mohamed Shelan
    Yasser Abo-Madyan
    Grit Welzel
    Christian Bolenz
    Julia Kosakowski
    Nadim Behnam
    Frederik Wenz
    Frank Lohr
    [J]. Radiation Oncology, 8
  • [42] Validation of the Decipher prostate cancer classifier in intermediate to high-risk men treated with radical prostatectomy but without additional therapy upon PSA rise.
    Ross, Ashley
    Yousefi, Kasra
    Trock, Bruce J.
    Choeurng, Voleak
    Lam, Lucia L. C.
    Fedor, Helen L.
    Ghadessi, Mercedeh
    Buerki, Christine
    Glavaris, Stephanie
    Sundi, Debasish
    Tosoian, Jeffrey
    Han, Misop
    Humphreys, Elizabeth B.
    Partin, Alan W.
    Netto, George J.
    Davicioni, Elai
    Schaeffer, Edward M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (07)
  • [43] Biochemical disease-free survival in patients with a high prostate-specific antigen level (20-100 ng/ml) and clinically localized prostate cancer after radical prostatectomy
    Neulander, EZ
    Wajsman, Z
    [J]. BJU INTERNATIONAL, 2003, 92 (07) : 824 - 824
  • [44] Biochemical disease-free survival in patients with a high prostate-specific antigen level (20-100 ng/mL) and clinically localized prostate cancer after radical prostatectomy
    Brandli, DW
    Koch, MO
    Foster, RS
    Bihrle, R
    Gardner, TA
    [J]. BJU INTERNATIONAL, 2003, 92 (01) : 19 - 22
  • [45] Dose-escalated salvage radiotherapy after radical prostatectomy in high risk prostate cancer patients: Outcome, prognostic factors and late toxicity
    Shelan, M.
    Welzel, G.
    Kosakowski, J.
    Behnam, N.
    Wenz, F.
    Abo-Madyan, Y.
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2012, 188 : 54 - 55
  • [46] Predicting survival in node-positive prostate cancer after open, laparoscopic or robotic radical prostatectomy: A competing risk analysis of a multi-institutional database
    Schiavina, Riccardo
    Bianchi, Lorenzo
    Borghesi, Marco
    Briganti, Alberto
    Brunocilla, Eugenio
    Carini, Marco
    Terrone, Carlo
    Mottrie, Alex
    Dente, Donato
    Gacci, Mauro
    Gontero, Paolo
    Gurioli, Alberto
    Imbimbo, Ciro
    La Manna, Gaetano
    Marchioro, Giansilvio
    Milanese, Giulio
    Mirone, Vincenzo
    Montorsi, Francesco
    Morgia, Giuseppe
    Munegato, Stefania
    Novara, Giacomo
    Panarello, Daniele
    Porreca, Angelo
    Russo, Giorgio I.
    Serni, Sergio
    Simonato, Alchide
    Urzi, Daniele
    Verze, Paolo
    Volpe, Alessandro
    Martorana, Giuseppe
    [J]. INTERNATIONAL JOURNAL OF UROLOGY, 2016, 23 (12) : 1000 - 1008
  • [47] Oncologic outcomes of open versus robotic-assisted radical prostatectomy for high-risk prostate cancer: a multi-institutional study of 13,567 men
    Sooriakumaran, P.
    Shariat, S. F.
    Srivastava, A.
    Grover, S.
    Chromecki, T.
    Tewari, A. K.
    [J]. BJU INTERNATIONAL, 2011, 108 : 59 - 59
  • [48] NOT ALL HIGH RISK PROSTATE CANCER PATIENTS HAVE THE SAME RISK OF BIOCHEMICAL RECURRENCE AFTER SURGERY. A MULTI-INSTITUTIONAL ANALYSIS OF PREDICTORS OF GOOD OUTCOME
    Riganti, Alberto
    Astian, Patrick J.
    Chun, Felix K. H.
    Gallina, Andrea
    Ahyai, Sascha A.
    Seitz, Michael
    Suardi, Nazareno
    Zacharias, Mario
    Buchner, Alexander
    Da Pozzo, Luigi F.
    Graefen, Markus
    Rigatti, Patrizio
    Stief, Christian G.
    Huland, Hartwig
    Montorsi, Francesco
    [J]. JOURNAL OF UROLOGY, 2009, 181 (04): : 290 - 290
  • [49] MULTI-INSTITUTIONAL PROSPECTIVE STUDY ASSESSING THE UNFAVORABLE SUBGROUP AMONG INTERMEDIATE-RISK LOCALIZED PROSTATE CANCER PATIENTS TREATED WITH RADICAL PROSTATECTOMY: IMPLICATIONS FOR PERSONALIZING TREATMENT OF RADICAL PROSTATECTOMY-MANAGED PATIENTS
    Ahallal, Youness
    Benfante, Nicole
    Durand, Matthieu
    Zanettini, Luis Felipe Snel
    Strauss, Christiane
    Colau, Alexandre
    Touijer, Karim
    Guillonneau, Bertrand
    [J]. JOURNAL OF UROLOGY, 2019, 201 (04): : E111 - E111
  • [50] CAN WE PREDICT LATE RECURRENCES AFTER RADICAL PROSTATECTOMY IN MEN WITH HIGH RISK PROSTATE CANCER? A VERY LONG TERM ANALYSIS FROM A LARGE, MULTI-INSTITUTIONAL ANALYSIS
    Bianchi, Marco
    Briganti, Alberto
    Karnes, Jeffrey R.
    Gandaglia, Giorgio
    Fossati, Nicola
    Spahn, Martin
    Gontero, Paolo
    Tosco, Lorenzo
    Kneitz, Burkhard
    Chun, Felix
    Zaffuto, Emanuele
    De Ridder, Dirk
    Sun, Maxine
    Graefen, Markus
    Marchioro, Giansilvio
    Frohneberg, Detlef
    Guilloneau, Bertrand
    Sanchez-Salas, Rafael
    Cathelineau, Xavier
    Giona, Simone
    Karakiewicz, Pierre
    Van Poppel, Hein
    Montorsi, Francesco
    Joniau, Steven
    [J]. JOURNAL OF UROLOGY, 2016, 195 (04): : E856 - E857